201 studies found for:    "Mesothelioma"
Show Display Options
RSS Create an RSS feed from your search for:
"Mesothelioma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
Conditions: Recurrent Malignant Mesothelioma;   Stage IA Malignant Mesothelioma;   Stage IB Malignant Mesothelioma;   Stage II Malignant Mesothelioma;   Stage III Malignant Mesothelioma;   Stage IV Malignant Mesothelioma
Interventions: Biological: oncolytic measles virus encoding thyroidal sodium iodide symporter;   Other: laboratory biomarker analysis;   Procedure: single photon emission computed tomography;   Procedure: computed tomography
2 Completed Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.
Conditions: Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma;   Stage IA Malignant Mesothelioma;   Stage IB Malignant Mesothelioma;   Stage II Malignant Mesothelioma;   Stage III Malignant Mesothelioma;   Stage IV Malignant Mesothelioma
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis
3 Completed Gefitinib in Treating Patients With Malignant Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: gefitinib;   Other: laboratory biomarker analysis
4 Active, not recruiting Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Localized Malignant Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: cediranib maleate;   Other: diagnostic laboratory biomarker analysis
5 Withdrawn AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Biological: rilotumumab;   Drug: cisplatin;   Drug: pemetrexed disodium;   Other: laboratory biomarker analysis
6 Recruiting Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: pemetrexed disodium;   Drug: cisplatin;   Drug: cediranib maleate;   Other: placebo
7 Completed Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
8 Completed PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: belinostat;   Other: laboratory biomarker analysis
9 Active, not recruiting Pazopanib in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Localized Malignant Mesothelioma;   Recurrent Malignant Mesothelioma
Interventions: Other: laboratory biomarker analysis;   Drug: pazopanib hydrochloride
10 Recruiting Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Pemetrexed;   Drug: Cisplatin
11 Active, not recruiting
Has Results
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Conditions: Pleural Mesothelioma;   Peritoneal Mesothelioma
Intervention: Drug: IMC-A12
12 Completed Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Epithelial Mesothelioma;   Localized Malignant Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatous Mesothelioma
Interventions: Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Biological: bevacizumab;   Other: placebo;   Other: laboratory biomarker analysis
13 Completed Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Recurrent Malignant Mesothelioma
Intervention: Drug: sunitinib malate
14 Unknown  Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma
Conditions: Pleural Mesothelioma;   Malignant Pleural Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Sodium Thiosulfate
15 Active, not recruiting Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Cisplatin;   Drug: Imatinib Mesylate;   Drug: Pemetrexed
16 Recruiting Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Condition: Mesothelioma
Intervention:
17 Active, not recruiting SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Drug: SS1P;   Drug: Pemetrexed;   Drug: Cisplatin
18 Recruiting Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Condition: Mesothelioma
Intervention: Drug: Velcade (bortezomib) plus Eloxatin (oxaliplatin)
19 Completed
Has Results
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
Condition: Mesothelioma
Interventions: Drug: pemetrexed disodium;   Drug: gemcitabine hydrochloride;   Drug: carboplatin
20 Active, not recruiting Tomotherapy Treatment for Mesothelioma
Condition: Mesothelioma
Intervention: Procedure: Tomotherapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years